H. Hass

发表

Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide Arrays

H. Hass, U. Vogel, M. Scheurlen, 2017, Gut and liver.

Signet Ring Cell Carcinoma of the Stomach Is Significantly Associated with Poor Prognosis and Diffuse Gastric Cancer (Lauren’s): Single-Center Experience of 160 Cases

H. Hass, O. Nehls, C. Denzlinger, 2011, Oncology Research and Treatment.

Long-term treatment of advanced hepatocellular carcinoma with the tyrosine kinase inhibitor erlotinib (Tarceva)--a case report.

H. Hass, C. Denzlinger, 2009, Zeitschrift fur Gastroenterologie.

Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial

M. Stauch, V. Heinemann, H. Hass, 2011, British Journal of Cancer.

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial

M. Stauch, V. Heinemann, H. Hass, 2014, Journal of Cancer Research and Clinical Oncology.

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

H. Hass, M. Gregor, B. Klump, 2002, British Journal of Cancer.

Prognostic Factors and Impact of Immunohistochemistry in the Management of Biliary Tract Cancer– A Single Center Experience in Germany

H. Hass, C. Denzlinger, U. Smith, 2018 .

Overexpression of Tumor-Associated Trypsin Inhibitor (SPINK1/TATI) in Hepatitis C-Associated Hepatocellular Carcinoma: Potential Implications for Viral Hepatocarcinogenesis

H. Hass, U. Vogel, M. Scheurlen, 2014, Oncology Research and Treatment.

Supportive care needs and quality of life in patients with breast and gynecological cancer attending inpatient rehabilitation. A prospective study

H. Hass, H. Faller, A. Wöckel, 2019, Acta oncologica.

Ligand expression of the EGFR ligands amphiregulin, epiregulin, and amplification of the EGFR gene to predict for treatment efficacy in KRAS wild-type mCRC patients treated with cetuximab plus CAPIRI and CAPOX: Analysis of the randomized AIO CRC-0104 trial.

M. Stauch, V. Heinemann, H. Hass, 2012 .

NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancer

K. Fliessbach, H. Hass, C. Hoppe, 2017, Psycho-oncology.

Subclinical and overt hepatic encephalopathy — detection and treatment control by proton magnetic resonance spectroscopy (1H-MRS)

I. Mader, H. Hass, M. Gregor, 2003 .

Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group.

M. Stauch, V. Heinemann, H. Hass, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX

H. Hass, J. Hartmann, C. Hsieh, 2007, British Journal of Cancer.

Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B

H. Hass, O. Nehls, T. Bock, 2009, Journal of Gastroenterology.

Early viral dynamics is a strong significant predictor for long-term response and occurence of YMDD mutations in patients treated with lamivudine for chronic Hepatitis B

H. Hass, O. Nehls, T. Bock, 2008 .

Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone

H. Hass, M. Gregor, C. Hsieh, 2009, International Journal of Colorectal Disease.

Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis.

Andrea Frilling, H. Hass, U. Vogel, 2008, World journal of gastroenterology.

Gene expression analysis for evaluation of potential biomarkers in hepatocellular carcinoma.

H. Hass, U. Vogel, M. Scheurlen, 2015, Anticancer research.

Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma.

H. Hass, U. Vogel, M. Scheurlen, 2016, Anticancer research.

Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

J. Trojan, H. Hass, H. Oettle, 2008, British Journal of Cancer.

Thyroid Disorders and Occurrence of Nonorgan-specific Autoantibodies (NOSA) in Patients With Chronic Hepatitis C Before and During Antiviral Induction Therapy With Consensus Interferon (Interferon Alfacon-1)

H. Hass, O. Nehls, R. Klein, 2009, Journal of clinical gastroenterology.

Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the Liver

H. Hass, U. Vogel, M. Scheurlen, 2018, Oncology.

Major prognostic impact of proapoptotic BAX protein expression in stage III (UICC) colon cancer treated by adjuvant chemotherapy

H. Hass, C. Hsieh, B. Klump, 2005 .

High-dose interferon-alpha2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-alpha monotherapy.

H. Hass, J. Menzel, S. Kaiser, 2005, World journal of gastroenterology.

Diagnostic and Prognostic Aspects of Hepatocellular Carcinoma – A Retrospective Analysis in 145 Patients

H. Hass, C. Denzlinger, U. Smith, 2017 .

Male Breast Cancer: Therapy-Induced Toxicities, Psychological Distress, and Individual Patient Goals during Oncological Inpatient Rehabilitation

H. Hass, A. Wöckel, A. Herzberger, 2022, Oncology Research and Treatment.

Psychological distress in breast cancer patients during oncological inpatient rehabilitation: incidence, triggering factors and correlation with treatment-induced side effects

H. Hass, A. Wöckel, J. Stepien, 2022, Archives of Gynecology and Obstetrics.

[Early and Late Toxicities and Socio-Medical Relevant Disorders after Oncological Treatment for Breast Cancer-Implications and Assessment of Rehabilitation Requirement].

M. Beckmann, H. Hass, A. Wöckel, 2021, Die Rehabilitation.

Patients' challenges, competencies, and perceived support in dealing with information needs - A qualitative analysis in patients with breast and gynecological cancer.

P. Heuschmann, H. Hass, H. Faller, 2021, Patient education and counseling.

Successful retreatment of peginterferon nonresponder patients with chronic hepatitis C with high dose consensus interferon induction therapy

H. Hass, M. Gregor, S. Kaiser, 2003 .

High dose induction therapy with consensus interferon and ribavirin for treatment-naive patients with hepatitis C

H. Hass, M. Gregor, S. Kaiser, 2002 .

DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.

H. Hass, O. Nehls, S. Kaiser, 2008, Oral oncology.

Patientenkompetenz zur Krankheitsbewältigung – Eine qualitative Analyse bei Frauen mit Brustkrebs und gynäkologischen Tumoren

P. Heuschmann, H. Hass, H. Faller, 2022, PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie.

Einfluss klinischer, sozialmedizinischer und psychologischer Faktoren auf die berufliche Reintegration von Patientinnen mit Brustkrebs 6 Monate nach der Rehabilitation

K. Fliessbach, H. Hass, C. Hoppe, 2021, Die Rehabilitation.

Randomized trial comparing cetuximab plus XELIRI versus cetuximab plus XELOX as first line treatment of patients with metastatic colorectal cancer (mCRC): A study of the german AIO CRC study group

M. Stauch, V. Heinemann, H. Hass, 2008 .

A prospective multicenter phase II trial of capecitabine plus oxaliplatin (CapOx) in advanced biliary system adenocarcinomas: The final results.

H. Hass, H. Oettle, M. Gregor, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].

T. Nägele, H. Hass, M. Gregor, 2005, Zeitschrift fur Gastroenterologie.